Bactiguard Holding
70 SEKBe the first to follow this company
Bactiguard is a global MedTech company that prevent infections related to medical devices. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation. Bactiguard operates through license partnerships with MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard has its headquarters in Stockholm.
Revenue
201.55M
EBIT %
-65.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BACTI B
Daily low / high price
-
Market cap
2.45B SEK
Turnover
-
Volume
-
Latest videos
Financial calendar
Interim report
16.07.2024
Interim report
24.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Thomas von Koch och bolag | 18.9 % | 34.6 % |
Christian Kinch med familj o bolag | 17.6 % | 34.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Carnegie Commissioned Research: Bactiguard: Sales need to pick up for the stock to move
Bactiguard, Audiocast with teleconference, Q1, 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools